Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
about
Dialysis Disequilibrium Syndrome: brain death following hemodialysis for metabolic acidosis and acute renal failure--a case reportRole of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapyNeurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment.Immunotherapy advances for glioblastomaA systematic literature review of cerebrospinal fluid biomarkers in deliriumBlood brain barrier: a challenge for effectual therapy of brain tumorsConcepts of immunotherapy for gliomaQuantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypesNeurodegenerative evidence in mice brains with cecal ligation and puncture-induced sepsis: preventive effect of the free radical scavenger edaravoneDifferential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.Supportive management of patients with brain tumors.Glioma-related edema: new insight into molecular mechanisms and their clinical implications.MRI reveals edema in larynx (but not in brain) during anaphylactic hypotension in anesthetized rats.Study of subclinical cerebral edema in diabetic ketoacidosis by magnetic resonance imaging T2 relaxometry and apparent diffusion coefficient maps.Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathwayIron supplement prevents lead-induced disruption of the blood-brain barrier during rat developmentEfficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study.Neuron-glial interactions in blood-brain barrier formation.Single vs. combination immunotherapeutic strategies for glioma.Overview of cellular immunotherapy for patients with glioblastoma.Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1.C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κBGhrelin prevents disruption of the blood-brain barrier after traumatic brain injury.Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in ratsEmerging targeted treatments for malignant glioma.The role of checkpoints in the treatment of GBMCharacterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer.Interleukin-1β induces the upregulation of caveolin-1 expression in a rat brain tumor model.Zero-valent Fe confined mesoporous silica nanocarriers (Fe(0) @ MCM-41) for targeting experimental orthotopic glioma in rats.A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery.Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema.Recent advances and future of immunotherapy for glioblastoma.Immunotherapeutic approaches for gliomaAlu methylation serves as a biomarker for non-invasive diagnosis of gliomaTripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation.Occludin is overexpressed in Alzheimer's disease and vascular dementia
P2860
Q21261412-CCD00B10-0520-4FA1-8E90-351FA3BE732BQ26741218-423F6EA9-A65E-4E25-8681-C634CD2F4D00Q26801485-FE4A3574-3FDB-48C8-BC7A-7CA575B306A0Q26866513-87242DA0-A257-4208-A578-827E954FD3BFQ27001646-1D24555E-639E-403F-8361-91AA89AEEF86Q28081947-77ECC784-B829-4921-BDE9-117CFBAAF9C1Q28083888-8FDE214B-3B97-4360-AADC-50135C6A6510Q28299872-FAB0795D-02A7-49BA-8056-2E5C6C8381CFQ28484248-2D16FC0F-CCB7-4D22-A24A-3E3487179E4FQ30428613-B1515ADF-3C1F-4216-9C72-FC4442DC0C09Q30444752-73BE0F0F-0D4F-4276-A674-1EB316A20F0EQ30581454-6643F31F-FC38-4E01-8ECC-3D29F2229585Q30687509-F4978AE1-6B37-43E3-B252-BABEA67C4321Q31030435-33C42D05-12AE-43A6-A8E6-D9581DBF9183Q31172625-BF5156A1-8C66-410E-A5E7-71AC75F9C883Q33269639-3E15663B-3720-400B-BBBA-930CE42035D2Q33364886-26B02173-23F5-48BA-8D2C-FE0E30DC0BE8Q33511587-146CB1FD-7FA6-46A5-BA97-7B46FBCC35C4Q33670796-C732A223-AE90-4154-87B5-616A48AC2D5FQ33746041-6674E7BB-394C-4991-9AEF-9F82CA3AAEC9Q34189694-D5A54D55-4C5E-420B-A68E-14A0CB3798DEQ34553348-EA7C35A8-8540-4045-80D0-0915AEDD7FD8Q35320816-408CEDC9-0C01-4A05-99D0-D32828170548Q35552398-073A12A4-2260-4739-B666-B3AACABE47B8Q35757736-A54F247D-3E9A-4CFE-8FBC-C68D60CD9633Q36173696-1DD6A986-B70C-42F5-9E98-754EB6A1A4B9Q36287281-1E97F349-1055-403B-AAA8-F1A13880504FQ36302855-9AE02EEB-0D64-4BDC-BC77-9C00ADA2CCA5Q36571197-68B06E60-3816-4A73-9DCB-2B8EF65C1F1FQ36721489-A1C7A631-2D17-428A-83A5-C00A65EA0F83Q36741533-F6B22C94-8C48-49FF-B6EB-A04A38A9E157Q37076642-54D9F008-919C-4942-A9FE-AF2B6C3FB8A6Q37089440-6C165BA5-ABE4-430B-A3F5-39B2A36E6097Q37110603-FA0A6F25-5D73-4714-9196-867EB30A0D2DQ37210210-520298C0-7DDA-40A3-9B81-45AEA9F16EAFQ37239071-FE9AE899-9050-47CB-BA2C-242712C80EECQ37267793-8859F775-D9DA-47F7-8E1B-C5FF8F3DF83BQ37295593-D2A55727-C7C6-4DE2-8BD9-55E9BE788973Q37332651-FB32A9E5-1DD0-4DC1-9764-15A3C9CCCD33Q37580203-161D57B3-F6B8-4692-BBAD-6E91B7BF6E58
P2860
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
@ast
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
@en
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
@nl
type
label
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
@ast
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
@en
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
@nl
prefLabel
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
@ast
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
@en
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
@nl
P1433
P1476
Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
@en
P2093
D C Davies
P304
P356
10.1046/J.1469-7580.2002.00065.X
P577
2002-06-01T00:00:00Z